{"name":"Emphycorp","slug":"emphycorp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPU3dSd3B5TnBVaXlnbFJaNW1fMmpJSDdQSzBNNy1fb2FkVkxMTG4tMWVxdF9wRndIUVVrNm1JNkdSWUlyNEJGUzRwNGZjLVNtTk9hTUQ3MnFvdFk1YkE4bXl0ZmtFZ1dLVTdyWkJfNTN0aFh3ZEUyREhtUVl5RTRSRmZLLVRGeWNWMi1pOVgyU2htQU5SczZROVBCQWFMeDk3YWRwcmVEYUtRNGs3bFE?oc=5","date":"2026-04-08","type":"pipeline","source":"Yahoo Finance","summary":"Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight - Yahoo Finance","headline":"Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPVGpBdFhwVlhwX3piazdBNjl1MERRTTdmZEpuOF80M0k0Nnd4OEZRZ3dTOTZ4aHlkUXJkUHA1Z0FYd211ejFCeGYtQmhRMmVadDRkZ1pnbF9xVHlEU1ZzOVByblZnQl90ZmJ2dE5VQk1yMEZvVUpvNDBRSU5hTjF4RHBpXzE1Zmh6T19HdXNGcGZrR0dZT2REVExXWXpyemNVT2Z1cTdvWW1Hck1xMG14OEhudmNqTmk0ZXhKYngxdHU5ekpRelpEVXNBMWhHQzRfOURScXdUN3ZSZVN5NWxXM2JBUnBoUTlCZHhXaGlrMDNPS1NWMkl0N1g0dHBFbkw5YlowMWNvNA?oc=5","date":"2026-03-12","type":"pipeline","source":"The Globe and Mail","summary":"Centri Announces Participating Companies for Second Annual Capital Conference at Nasdaq - The Globe and Mail","headline":"Centri Announces Participating Companies for Second Annual Capital Conference at Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNWlVGdDN2UzQwLVo4Uy13Nkx5dFBJcnltRHZJNlYxRXF6b1RuOWRVcmYxQ2VGUnZUTjlDdkF2RkNxaU9XYjZ6RVNVbThkSHZodnJ1MFdQNXJDVkc1UkRnT0lNUG9YRHc4WG1ZWWxaemhkU18xck85ZzExZmVvRjg2TEktalJCSFNPV3E5OVlZaDFTX3ZyMlI0SDRIdw?oc=5","date":"2025-08-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"PureTech forms respiratory spin-off Celea to advance deuterated pirfenidone - Pharmaceutical Technology","headline":"PureTech forms respiratory spin-off Celea to advance deuterated pirfenidone","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQZXQyc1JuU2tCZEwzQkV5RWtGWG8yV1ZQaXpmNndaNmRDdV9mTUtLcjk5cHVFUXkxZGUzbG5iT09SWEFxNlRhYjlnQkNOMjNWT3N5Yk1LS0F2Z1NEUkpKWlE3c0hEaHJsVlU2c19fTEp0XzlKamlPeG5RNGItb2Y2dEtoVThJRGhVVHRINkdn?oc=5","date":"2025-07-10","type":"trial","source":"Yahoo Finance","summary":"Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance","headline":"Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQRE0tVHFDTkFjR0pnOEVHY2RxaEFtc3Nna2piVk9FZEg3VjhhOTJSb2FvWGpRdFhJRlFvNVdOV3FfYkJTNGVaSEVGbVpPWjh3REFta3NxM2tSckNkX3dBNVFNWTNUeHdtcVRtdDc0bTMzMVNlTHF6MnNDTUFDcWMxV3dzYmNJbWxUbDJSeGhFdC1wMnU5bG9hZ1h5MDRHM0tWS09WM0xZWkkzUXpOZlNEc25QVmlRNndvZExKZjV0VWFBVlNPTXM1SUJ3em11VzByRUhndk1wRE1ILWVMOUxjXzBXYw?oc=5","date":"2024-09-09","type":"pipeline","source":"PR Newswire","summary":"Idiopathic Pulmonary Fibrosis Treatment Drug Market to Increase 2 Folds by 2034 | DelveInsight - PR Newswire","headline":"Idiopathic Pulmonary Fibrosis Treatment Drug Market to Increase 2 Folds by 2034 | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}